Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
222.40    -0.20 (-0.09%)
Bid:
222.00
Ask:
222.40
Spread: 0.40 (0.18%)
Market Cap: £2.27b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Bond Refinancing

23 May 2024 07:00

RNS Number : 6250P
Helios Towers PLC
23 May 2024
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933 (THE "U.S. SECURITIES ACT")) OR IN OR INTO ANY OTHER JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

HELIOS TOWERS ANNOUNCES PRICING OF U.S.$850 MILLION AGGREGATE PRINCIPAL AMOUNT OF 7.500% SENIOR NOTES DUE 2029

May 23, 2024 - HTA Group, Ltd (the "HTA Group"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the successful pricing of its offering of 7.500% Senior Notes due 2029 (the "Notes"), guaranteed on a senior basis by the Company and certain of its subsidiaries (the "Offering").

The Notes will be issued at an issue price of 99.488% of principal amount. HTA Group will pay interest on the Notes semi-annually in arrears on each June 4 and December 4, commencing on December 4. 2024.

The proceeds of the Notes will be used (i) to repurchase any and all of the outstanding U.S.$650,022,000 in aggregate principal amount of the HTA Group's 7.000% Senior Notes due 2025 (the "Existing Notes") pursuant to the Tender Offer (as defined below), (ii) with respect of the Existing Notes that are not repurchased in the Tender Offer, to redeem in full the remaining Existing Notes, (iii) to partially repay amounts drawn under the Pari Passu Term Loan Facilities, (iv) to repay amounts drawn under the Senegal OpCo Facilities in full, (v) to pay certain fees, expenses and break costs in relation to the foregoing, and (vi) to pay accrued interest on the Existing Notes to the date of repurchase and/or redemption.

On May 20, 2024, HTA Group announced a tender offer (the "Tender Offer") for any and all of the outstanding U.S.$650,022,000 of aggregate principal amount of the Existing Notes pursuant to an offer to purchase dated the same date.

Manjit Dhillon, Chief Financial Officer, said:

"We are delighted to announce the successful pricing of our bond offering. The offering was three times oversubscribed, achieving a peak orderbook of U.S.$2.5 billion. Importantly, despite the materially higher rate environment since our last bond issuance, we expect only a 10bps change in our cost of debt from this refinancing exercise, that also includes repaying a portion of our Group and Senegal term facilities with the new proceeds, while at the same time extending our average debt maturity by two years, to extend our average remaining life to five years.

This successful refinancing reflects the Company's track record and market diversification since our last bond offering, and expected cash flow generation through to 2026. This has also been demonstrated through our rating upgrades by both Moody's and S&P to B+ equivalent, and Fitch updating their outlook to positive.

We thank our bond investors for their ongoing support in the Company and look forward to delivering value for all stakeholders through our Sustainable Business Strategy in the years ahead."

* * * * *

For the purposes of MAR, the person responsible for making this announcement is Paul Barrett, General Counsel and Company Secretary.

This announcement is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Notes or the Existing Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such offer, solicitation or sale would be unlawful. The Notes and the guarantees in respect thereof have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction. Securities may not be offered in the United States absent registration or an exemption from registration. No action has been or will be taken in any jurisdiction in relation to the Notes to permit a public offering of securities. There is no assurance that any Notes offering will be completed or, if completed, as to the terms on which it is completed.

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive 2016/97/EU (as amended, the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPS Regulation.

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (the "UK"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the "FSMA") and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by the PRIIPs Regulation as it forms part of domestic law by virtue of the EUWA (the "UK PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

FCA/ICMA Stabilisation

MiFID II / UK MiFIR professionals/ECPs-only / No PRIIPs KID - Manufacturer target market (MiFID II / UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in the EEA or the United Kingdom.

In addition, this announcement is being distributed to, and is directed at, only persons who (i) are outside the United Kingdom; (ii) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article 19(5) of the Financial Promotion Order; (iii) fall within Article 49(2)(a) to (d) of the Financial Promotion Order; or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA in connection with the issue or sale of any Notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). The investments to which this announcement relates are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such investments will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. Persons distributing this announcement must satisfy themselves that it is lawful to do so.

The distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such jurisdiction.

Forward-Looking Information

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Company concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Company and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEISIDELSEEI
Date   Source Headline
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding
7th Jun 20229:57 amRNSOmantel Tower Acquisition Update
5th May 202210:30 amRNSCapital Markets Day 2022
5th May 20227:00 amRNSQ1 2022 Results
29th Apr 202212:29 pmRNSDirector/PDMR Shareholding
28th Apr 20222:58 pmRNS2022 Annual General Meeting Results
20th Apr 202212:37 pmRNSNotice of Q1 2022 Results Date and CMD
28th Mar 20222:04 pmRNS2021 Annual Report & Accounts & 2022 Notice of AGM
25th Mar 20227:00 amRNSClosing of tower acquisition in Malawi
24th Mar 20229:11 amRNSDirector Declaration
21st Mar 20225:08 pmRNS2021 Annual Report and Accounts
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSBoard Update - Director Changes
25th Feb 20227:00 amRNSAirtel Africa Tower Portfolio Transactions Update
11th Feb 20227:00 amRNSOmantel tower acquisition long-stop date extension
2nd Feb 20229:00 amRNSNotice of FY2021 Results Date & Conference Call
14th Dec 20212:12 pmRNSHolding(s) in Company
1st Dec 20215:12 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSCarbon Reduction Roadmap
3rd Nov 20217:00 amRNSClosing of tower acquisition in Madagascar
28th Oct 20217:00 amRNSQ3 2021 Results
22nd Oct 20218:25 amRNSDirector Declaration
11th Oct 20217:00 amRNSNotice of Q3 2021 Results Date & Conference Call
27th Sep 20213:33 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSUnaudited results for the 6 months ended 30 Jun 21
18th Aug 20215:00 pmRNSHelios Towers Announces CEO Transition
4th Aug 20217:00 amRNSNotice of H1 2021 Results Date & Conference Call
2nd Jul 20219:48 amRNSHolding(s) in Company
2nd Jul 20219:47 amRNSDirector/PDMR Shareholding
30th Jun 20216:11 pmRNSHolding(s) in Company
30th Jun 202111:12 amRNSTotal Voting Rights
18th Jun 20219:25 amRNSTotal Voting Rights
17th Jun 202112:46 pmRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSResults of Placing
15th Jun 20215:06 pmRNSRetail Offer via Primary Bid
15th Jun 20214:57 pmRNSLaunch of placing & convertible bond tap issuance
4th Jun 202112:46 pmRNSResult of General Meeting
3rd Jun 20215:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.